Self-assembled carrier-free nanomedicine suppresses tumor stemness to overcome the acquired drug-resistance of hepatocellular carcinoma

Nanocatalytic Theranostics with Glutathione Depletion and Enhanced Reactive Oxygen Species Generation for Efficient Cancer Therapy

Lian‐Hua Fu, Yilin Wan, Chao Qi et al. · Advanced Materials · 2021 · 810 citations

Pharmacy, Oncology, Pharmacology +17

Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen Species

Ping’an Ma, Haihua Xiao, Yu Chang et al. · Nano Letters · 2017 · 654 citations

Medicine, Oncology, Pharmacology +17

MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation

Kyung‐min Lee, Jennifer M. Giltnane, Justin M. Balko et al. · Cell Metabolism · 2017 · 646 citations · Full text

Medicine, Cell Biology, Oncology +12

Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC

Lai Wei, Derek Lee, Cheuk‐Ting Law et al. · Nature Communications · 2019 · 445 citations · Full text

Life Sciences, Genetics, Oncology +16

Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma

Yingjian Liang, Tongsen Zheng, Ruipeng Song et al. · Hepatology · 2013 · 293 citations

Medicine, Oncology, Pharmacology +16